121 related articles for article (PubMed ID: 6982734)
1. Cytotoxic T-cell clones derived from pluripotent stem cells (CFU-GEMM) of patients with Hodgkin's lymphoma.
Fauser AA; Neumann HA; Bross KG; Kanz L; Löhr GW
Blood; 1982 Dec; 60(6):1317-20. PubMed ID: 6982734
[TBL] [Abstract][Full Text] [Related]
2. Suppressor T-cell clones derived from pluripotent stem cells (CFU-GEMM) of a patient with Hodgkin's lymphoma.
Fauser AA; Bross KG; Kanz L; Löhr GW
Blut; 1982 Aug; 45(2):97-102. PubMed ID: 6213280
[TBL] [Abstract][Full Text] [Related]
3. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential.
Carow CE; Hangoc G; Cooper SH; Williams DE; Broxmeyer HE
Blood; 1991 Nov; 78(9):2216-21. PubMed ID: 1718490
[TBL] [Abstract][Full Text] [Related]
4. Enrichment of pluripotent hemopoietic progenitor cells from human bone marrow.
Bodger MP; Hann IM; Maclean RF; Beard ME
Blood; 1984 Oct; 64(4):774-9. PubMed ID: 6332653
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocytic cells in mixed haemopoietic colonies (CFU-GEMM) from the peripheral blood of normal individuals.
Ganser A; Elstner E; Hoelzer D
Br J Haematol; 1985 Apr; 59(4):627-33. PubMed ID: 3986135
[TBL] [Abstract][Full Text] [Related]
6. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
[TBL] [Abstract][Full Text] [Related]
7. Recloned colonies positive for T-cell-associated antigens derived from mixed hemopoietic colonies (CFU-GEMM)1.
Fauser AA; Löhr GW
Proc Soc Exp Biol Med; 1982 Jun; 170(2):220-4. PubMed ID: 6979753
[No Abstract] [Full Text] [Related]
8. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
9. Surface phenotypes of human hemopoietic progenitor cells defined by monoclonal antibodies.
Ferrero D; Gabbianelli M; Peschle C; Lange B; Rovera G
Blood; 1985 Sep; 66(3):496-502. PubMed ID: 4027376
[TBL] [Abstract][Full Text] [Related]
10. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma.
Carow CE; Hangoc G; Broxmeyer HE
Blood; 1993 Feb; 81(4):942-9. PubMed ID: 7679010
[TBL] [Abstract][Full Text] [Related]
11. Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.
Nakahata T; Ogawa M
Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3843-7. PubMed ID: 6954527
[TBL] [Abstract][Full Text] [Related]
12. Clonal origin of human basophil/mast cells from circulating multipotent hemopoietic progenitors.
Denburg JA; Messner H; Lim B; Jamal N; Telizyn S; Bienenstock J
Exp Hematol; 1985 Mar; 13(3):185-8. PubMed ID: 3979471
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of hematopoiesis after bone marrow purging with ricin A chain immunotoxin.
Fauser AA; Kanz L; Casellas P; Laurent G; Cooper BA; Löhr GW
Transplantation; 1986 Mar; 41(3):356-60. PubMed ID: 3485318
[TBL] [Abstract][Full Text] [Related]
14. Clonal nature of murine hemopoietic blast cell colonies.
Fujimori Y; Hara H; Taguchi T; Kitamura Y; Nagai K
Blut; 1988 Oct; 57(4):169-73. PubMed ID: 3167226
[TBL] [Abstract][Full Text] [Related]
15. Two classes of primitive pluripotent hemopoietic progenitor cells: separation by adherence.
Kerk DK; Henry EA; Eaves AC; Eaves CJ
J Cell Physiol; 1985 Oct; 125(1):127-34. PubMed ID: 4044666
[TBL] [Abstract][Full Text] [Related]
16. Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow.
Neumann HA; Fauser AA
Exp Hematol; 1982 Aug; 10(7):587-90. PubMed ID: 6182013
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the T lymphocyte colony-forming cells and evidence for the acquisition of T cell markers in the absence of the thymic microenvironment in man.
Triebel F; Robinson WA; Hayward AR; de Laforest PG
J Immunol; 1981 May; 126(5):2020-3. PubMed ID: 6971318
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of mixed colony-forming cells in normal human bone marrow and blood.
Dresch C; Barreau P
Exp Hematol; 1985 Dec; 13(11):1143-51. PubMed ID: 4065263
[TBL] [Abstract][Full Text] [Related]
19. Differentiation from precursors in normal bone marrow of spontaneously cytotoxic cells showing anti-self-MHC specificity.
Benveniste P; Miller RG
J Immunol; 1986 Jun; 136(12):4399-406. PubMed ID: 2423593
[TBL] [Abstract][Full Text] [Related]
20. Methods for measuring suppression of hematopoiesis.
Chervenick PA
Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
